1. Home
  2. AMRC vs PCRX Comparison

AMRC vs PCRX Comparison

Compare AMRC & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ameresco Inc.

AMRC

Ameresco Inc.

N/A

Current Price

$29.21

Market Cap

1.8B

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

N/A

Current Price

$26.58

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMRC
PCRX
Founded
2000
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.0B
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
AMRC
PCRX
Price
$29.21
$26.58
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$33.22
$32.86
AVG Volume (30 Days)
483.5K
761.2K
Earning Date
11-03-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
18.87
N/A
EPS
1.19
0.47
Revenue
$1,883,767,000.00
$716,791,000.00
Revenue This Year
$9.67
$6.24
Revenue Next Year
$9.89
$9.53
P/E Ratio
$24.88
$55.55
Revenue Growth
12.22
3.14
52 Week Low
$8.49
$18.17
52 Week High
$44.93
$27.64

Technical Indicators

Market Signals
Indicator
AMRC
PCRX
Relative Strength Index (RSI) 31.18 69.80
Support Level $28.69 $25.17
Resistance Level $36.02 $27.16
Average True Range (ATR) 1.51 0.98
MACD -0.34 0.25
Stochastic Oscillator 6.49 85.16

Price Performance

Historical Comparison
AMRC
PCRX

About AMRC Ameresco Inc.

Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of its revenue from the U.S. Regions segment.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: